{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:34:53Z","timestamp":1787312093480,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure, and death. Recent studies suggest that early-onset AF increases the risk of developing heart failure and dilated cardiomyopathy. This study aimed to identify genetic variants in a large set of 34 cardiomyopathy genes among early-onset AF individuals. We conducted targeted sequencing of cardiomyopathy-associated genes in 478 individuals from a Danish cohort with early AF onset. Additionally, we analyzed whole exome sequencing data from 375,869 individuals from the UK Biobank, including 29,267 individuals with AF. Of the Danish individuals with early-onset AF, 8.8% carried pathogenic or likely pathogenic (P\/LP) variants in cardiomyopathy-associated genes. The prevalence of rare P\/LP variants in the UK Biobank analysis ranged from 3.85% in the group with early AF onset to 1.03% in the group without AF diagnosis. Results were largely consistent when excluding individuals with no prior cardiomyopathy or heart failure diagnosis. This suggests that genetic testing for cardiomyopathy could be relevant in selected individuals with early AF diagnosis.<\/jats:p>","DOI":"10.1038\/s41431-026-02119-5","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:44:11Z","timestamp":1777567451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of deleterious variants in cardiomyopathy genes in early-onset atrial fibrillation"],"prefix":"10.1038","author":[{"given":"Oliver Bundgaard","family":"Vad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quim Bech","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid Filt","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-544X","authenticated-orcid":false,"given":"Christian","family":"Paludan-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-8515","authenticated-orcid":false,"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-1844","authenticated-orcid":false,"given":"Pia Rengtved","family":"Lundegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2119_CR1","doi-asserted-by":"publisher","unstructured":"Vinter N, Cordsen P, Johnsen SP, Staerk L, Benjamin EJ, Frost L, et al. Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study. BMJ. 2024;e077209. https:\/\/doi.org\/10.1136\/bmj-2023-077209","DOI":"10.1136\/bmj-2023-077209"},{"key":"2119_CR2","doi-asserted-by":"publisher","unstructured":"Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;i4482. https:\/\/doi.org\/10.1136\/bmj.i4482","DOI":"10.1136\/bmj.i4482"},{"key":"2119_CR3","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/eurheartj\/ehae216","volume":"45","author":"C Paludan-M\u00fcller","year":"2024","unstructured":"Paludan-M\u00fcller C, Vad OB, Stampe NK, Diederichsen SZ, Andreasen L, Monfort LM, et al. Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality. Eur Heart J. 2024;45:2119\u201329. https:\/\/doi.org\/10.1093\/eurheartj\/ehae216.","journal-title":"Eur Heart J"},{"key":"2119_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jacbts.2023.08.008","volume":"9","author":"OB Vad","year":"2024","unstructured":"Vad OB, Angeli E, Liss M, Ahlberg G, Andreasen L, Christophersen IE, et al. Loss of Cardiac Splicing Regulator RBM20 Is Associated With Early-Onset Atrial Fibrillation. JACC: Basic Transl Sci. 2024;9:163\u201380. https:\/\/doi.org\/10.1016\/j.jacbts.2023.08.008.","journal-title":"JACC: Basic Transl Sci"},{"key":"2119_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/eurheartj\/ehaf793","volume":"47","author":"OB Vad","year":"2026","unstructured":"Vad OB, van Vreeswijk N, Yassin AS, Blaauw Y, Paludan-M\u00fcller C, Kanters JK, et al. Atrial cardiomyopathy: markers and outcomes. Eur Heart J. 2026;47:235\u201346. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf793.","journal-title":"Eur Heart J"},{"key":"2119_CR6","doi-asserted-by":"publisher","unstructured":"Vad OB, Monfort LM, Paludan-M\u00fcller C, Kahnert K, Diederichsen SZ, Andreasen L, et al. Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk. JAMA Cardiol. 2024;e241528. https:\/\/doi.org\/10.1001\/jamacardio.2024.1528.","DOI":"10.1001\/jamacardio.2024.1528"},{"key":"2119_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jacep.2022.11.022","volume":"9","author":"MS Kandola","year":"2023","unstructured":"Kandola MS, Kulm S, Kim LK, Markowitz SM, Liu CF, Thomas G, et al. Population-Level Prevalence of Rare Variants Associated With Atrial Fibrillation and its Impact on Patient Outcomes. JACC Clin Electrophysiol. 2023;9:1137\u201346. https:\/\/doi.org\/10.1016\/j.jacep.2022.11.022.","journal-title":"JACC Clin Electrophysiol"},{"key":"2119_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jacc.2025.06.052","volume":"86","author":"SJ Jurgens","year":"2025","unstructured":"Jurgens SJ, Melloni GEM, Kany S, Fabritz L, R\u00e4m\u00f6 JT, Goette A, et al. Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants. J Am Coll Cardiol. 2025;86:738\u201353. https:\/\/doi.org\/10.1016\/j.jacc.2025.06.052.","journal-title":"J Am Coll Cardiol"},{"key":"2119_CR9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jamacardio.2021.3370","volume":"6","author":"ZT Yoneda","year":"2021","unstructured":"Yoneda ZT, Anderson KC, Quintana JA, O\u2019Neill MJ, Sims RA, Glazer AM, et al. Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes. JAMA Cardiol. 2021;6:1371 https:\/\/doi.org\/10.1001\/jamacardio.2021.3370.","journal-title":"JAMA Cardiol"},{"key":"2119_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/jamacardio.2022.0810","volume":"7","author":"ZT Yoneda","year":"2022","unstructured":"Yoneda ZT, Anderson KC, Ye F, Quintana JA, O\u2019Neill MJ, Sims RA, et al. Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes. JAMA Cardiol. 2022;7:733 https:\/\/doi.org\/10.1001\/jamacardio.2022.0810.","journal-title":"JAMA Cardiol"},{"key":"2119_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamacardio.2025.0460","volume":"10","author":"LFJM Wijdeveld","year":"2025","unstructured":"Wijdeveld LFJM, Ajufo E, Challa SP, R\u00e4m\u00f6 JT, Wang X, Kany S, et al. Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation. JAMA Cardiol. 2025;10:564\u201373. https:\/\/doi.org\/10.1001\/jamacardio.2025.0460.","journal-title":"JAMA Cardiol"},{"key":"2119_CR12","doi-asserted-by":"publisher","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149. https:\/\/doi.org\/10.1161\/CIR.0000000000001193","DOI":"10.1161\/CIR.0000000000001193"},{"key":"2119_CR13","doi-asserted-by":"publisher","unstructured":"Laws JL, Shabani M, Williams HL, Grauherr DD, Kilbourne WM, Crawford DM, et al. Genetic evaluation of early-onset atrial fibrillation: impact on patient management. Eur Heart J. 2025;ehaf829. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf829.","DOI":"10.1093\/eurheartj\/ehaf829"},{"key":"2119_CR14","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1093\/eurheartj\/ehae298","volume":"45","author":"S Kany","year":"2024","unstructured":"Kany S, Jurgens SJ, R\u00e4m\u00f6 JT, Christophersen IE, Rienstra M, Chung MK, et al. Genetic testing in early-onset atrial fibrillation. Eur Heart J. 2024;45:3111\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/ehae298.","journal-title":"Eur Heart J"},{"key":"2119_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/14017431.2012.673728","volume":"46","author":"TA Rix","year":"2012","unstructured":"Rix TA, Riahi S, Overvad K, Lundbye-Christensen S, Schmidt EB, Joensen AM. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Card J. 2012;46:149\u201353. https:\/\/doi.org\/10.3109\/14017431.2012.673728.","journal-title":"Scand Card J"},{"key":"2119_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2010;26:589\u201395. https:\/\/doi.org\/10.1093\/bioinformatics\/btp698.","journal-title":"Bioinformatics"},{"key":"2119_CR17","doi-asserted-by":"publisher","unstructured":"Van Der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ Data to High-Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline. CP in Bioinformatics. 2013;43. https:\/\/doi.org\/10.1002\/0471250953.bi1110s43","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"2119_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06618-y","volume":"9","author":"G Ahlberg","year":"2018","unstructured":"Ahlberg G, Refsgaard L, Lundegaard PR, Andreasen L, Ranthe MF, Linscheid N, et al. Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation. Nat Commun. 2018;9:4316. https:\/\/doi.org\/10.1038\/s41467-018-06618-y.","journal-title":"Nat Commun"},{"key":"2119_CR19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186:1026\u201334. https:\/\/doi.org\/10.1093\/aje\/kwx246.","journal-title":"Am J Epidemiol"},{"key":"2119_CR20","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLoS Med. 2015;12:e1001779 https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"2119_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman JD, Li AH, Marcketta A, Sun D, Mbatchou J, Kessler MD, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599:628\u201334. https:\/\/doi.org\/10.1038\/s41586-021-04103-z.","journal-title":"Nature"},{"key":"2119_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation. 2021;144:7\u201319. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.053033.","journal-title":"Circulation"},{"key":"2119_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jacc.2024.12.010","volume":"85","author":"S Hespe","year":"2025","unstructured":"Hespe S, Waddell A, Asatryan B, Owens E, Thaxton C, Adduru ML, et al. Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel. J Am Coll Cardiol. 2025;85:727\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2024.12.010.","journal-title":"J Am Coll Cardiol"},{"key":"2119_CR24","doi-asserted-by":"publisher","first-page":"e003273","DOI":"10.1161\/CIRCGEN.120.003273","volume":"14","author":"CA James","year":"2021","unstructured":"James CA, Jongbloed JDH, Hershberger RE, Morales A, Judge DP, Syrris P, et al. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework. Circ Genom Precis Med. 2021;14:e003273. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003273.","journal-title":"Circ Genom Precis Med"},{"key":"2119_CR25","doi-asserted-by":"publisher","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","volume":"7","author":"AM Roberts","year":"2015","unstructured":"Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015;7:270ra6. https:\/\/doi.org\/10.1126\/scitranslmed.3010134.","journal-title":"Sci Transl Med"},{"key":"2119_CR26","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137. https:\/\/doi.org\/10.1093\/nar\/gkx1153.","journal-title":"Nucleic Acids Res"},{"key":"2119_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen \u2014 The Clinical Genome Resource. N Engl J Med. 2015;372:2235\u201342. https:\/\/doi.org\/10.1056\/NEJMsr1406261.","journal-title":"N Engl J Med"},{"key":"2119_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308\u201311. https:\/\/doi.org\/10.1093\/nar\/29.1.308.","journal-title":"Nucleic Acids Res"},{"key":"2119_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6:80\u201392. https:\/\/doi.org\/10.4161\/fly.19695.","journal-title":"Fly"},{"key":"2119_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535\u201348. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015.","journal-title":"Cell"},{"key":"2119_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99747-2","volume":"11","author":"C Rowlands","year":"2021","unstructured":"Rowlands C, Thomas HB, Lord J, Wai HA, Arno G, Beaman G, et al. Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders. Sci Rep. 2021;11:20607. https:\/\/doi.org\/10.1038\/s41598-021-99747-2.","journal-title":"Sci Rep"},{"key":"2119_CR32","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1093\/nar\/gkac686","volume":"50","author":"K Li","year":"2022","unstructured":"Li K, Luo T, Zhu Y, Huang Y, Wang A, Zhang D, et al. Performance evaluation of differential splicing analysis methods and splicing analytics platform construction. Nucleic Acids Res. 2022;50:9115\u201326. https:\/\/doi.org\/10.1093\/nar\/gkac686.","journal-title":"Nucleic Acids Res"},{"key":"2119_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"2119_CR34","volume-title":"RStudio: Integrated Development Environment for R [Internet]","author":"RStudio Team","year":"2020","unstructured":"RStudio Team RStudio: Integrated Development Environment for R [Internet]. Boston, MA: RStudio, PBC.; 2020. Available from http:\/\/www.rstudio.com\/."},{"key":"2119_CR35","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/CIRCRESAHA.122.319835","volume":"130","author":"J Lukas Laws","year":"2022","unstructured":"Lukas Laws J, Lancaster MC, Ben Shoemaker M, Stevenson WG, Hung RR, Wells Q, et al. Arrhythmias as Presentation of Genetic Cardiomyopathy. Circ Res. 2022;130:1698\u2013722. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.319835.","journal-title":"Circ Res"},{"key":"2119_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jprot.2016.07.020","volume":"148","author":"I Izquierdo","year":"2016","unstructured":"Izquierdo I, Rosa I, Bravo SB, Guiti\u00e1n E, P\u00e9rez-Serra A, Campuzano O, et al. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy. J Proteom. 2016;148:75\u201384. https:\/\/doi.org\/10.1016\/j.jprot.2016.07.020.","journal-title":"J Proteom"},{"key":"2119_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20114-9","volume":"8","author":"T Tobita","year":"2018","unstructured":"Tobita T, Nomura S, Fujita T, Morita H, Asano Y, Onoue K, et al. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep. 2018;8:1998. https:\/\/doi.org\/10.1038\/s41598-018-20114-9.","journal-title":"Sci Rep"},{"key":"2119_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally EM, Mestroni L. Dilated cardiomyopathy: Genetic determinants and mechanisms. Circ Res. 2017;121:731\u201348. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309396.","journal-title":"Circ Res"},{"key":"2119_CR39","doi-asserted-by":"publisher","unstructured":"Paludan-M\u00fcller C, Larsen S, Ahlberg G, Andreasen L, Monfort LM, Svendsen JH, et al. Clinical Implications of SCN10A Loss-of-Function Variants in 169 610 Exomes Representing the General Population. Circ: Genomic and Precision Medicine. 2022;15. https:\/\/doi.org\/10.1161\/CIRCGEN.121.003574","DOI":"10.1161\/CIRCGEN.121.003574"},{"key":"2119_CR40","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.3390\/ijms241310510","volume":"24","author":"BS Tudurachi","year":"2023","unstructured":"Tudurachi BS, Z\u0103voi A, Leonte A, \u021a\u0103poi L, Ureche C, B\u00eergoan SG, et al. An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy. IJMS. 2023;24:10510 https:\/\/doi.org\/10.3390\/ijms241310510.","journal-title":"IJMS"},{"key":"2119_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ng.3719","volume":"49","author":"S Schafer","year":"2017","unstructured":"Schafer S, De Marvao A, Adami E, Fiedler LR, Ng B, Khin E, et al. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet. 2017;49:46\u201353. https:\/\/doi.org\/10.1038\/ng.3719.","journal-title":"Nat Genet"},{"key":"2119_CR42","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1001\/jama.2018.18179","volume":"320","author":"SH Choi","year":"2018","unstructured":"Choi SH, Weng LC, Roselli C, Lin H, Haggerty CM, Shoemaker MB, et al. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018;320:2354 https:\/\/doi.org\/10.1001\/jama.2018.18179.","journal-title":"JAMA"},{"key":"2119_CR43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s12551-018-0437-0","volume":"10","author":"AK Vimalanathan","year":"2018","unstructured":"Vimalanathan AK, Ehler E, Gehmlich K. Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy. Biophys Rev. 2018;10:973\u201382. https:\/\/doi.org\/10.1007\/s12551-018-0437-0.","journal-title":"Biophys Rev"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02119-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02119-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02119-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:12:43Z","timestamp":1782479563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02119-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":43,"alternative-id":["2119"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02119-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7971912\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JHS reports grants and speaker fee from Medtronic not related to the current study and is a member of an advisory board in Medtronic And Vital Beats. The remaining authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants gave written informed consent. The study of the Danish cohort was approved by the scientific ethics committee of the Capital Region of Denmark (protocol number: H-20048862). The UK Biobank was accessed under application number 43247. The UK Biobank received ethical approval from the North West Multi-Centre Research Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}